Hemalatha G. Rangarajan

This researcher studies hematopoietic (blood-forming) stem cell transplantation and gene therapy approaches for treating sickle cell disease, thalassemia, and other blood disorders in children and adults. Recent work focuses on transplant outcomes, complications like graft-versus-host disease and transplant-associated thrombotic microangiopathy, and emerging gene-editing therapies (such as CRISPR-based treatments) for sickle cell disease. Much of this research involves large multicenter collaborations and registry studies to track long-term patient outcomes.

Publication output has grown over the last decade, roughly doubling from about 11 papers per year in 2017 to over 20 per year in recent years, with some year-to-year fluctuation.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026